# A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

> **NCT03114254** · PHASE2 · COMPLETED · sponsor: **University Hospitals Bristol and Weston NHS Foundation Trust** · enrollment: 17 (actual)

## Conditions studied

- Penile Neoplasm

## Interventions

- **DRUG:** Cabazitaxel

## Key facts

- **NCT ID:** NCT03114254
- **Lead sponsor:** University Hospitals Bristol and Weston NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-05
- **Primary completion:** 2016-11-16
- **Final completion:** 2016-11-16
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03114254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03114254, "A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03114254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*